J Korean Child Neurol Soc.  2017 Sep;25(3):195-199. 10.26815/jkcns.2017.25.3.195.

A Novel c.826G>A Mutation in a Boy with Allan-Herndon-Dudley Syndrome: Clinical Significance of Thyroid Function Tests in Developmental Delay of Unknown Origin

Affiliations
  • 1Department of Pediatrics, Hanyang University Medical Center, Hanyang University College of Medicine, Seoul, Korea. jinhwamoon@hanyang.ac.kr
  • 2Medical Genetics Center, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

Abstract

Allan-Herndon-Dudley syndrome (AHDS) is an X-linked intellectual disability caused by monocarboxylate transporter 8 (MCT8) deficiency. AHDS manifests in global developmental delay, axial hypotonia, quadriplegia, movement disorders in male patients, and most of them show the delayed or hypomyelination on brain magnetic resonance images. Typically, Triiodothyronine (T3) levels are markedly elevated, thyroid stimulating hormone (TSH) levels are normal or elevated, and free thyroxine (T4) levels are normal or decreased. In AHDS patients, early neurological manifestations are easily mistaken as cerebral palsy with unknown origin. Here, we present a novel c.826G>A mutation in a boy with severe axial hypotonia, limb dystonia and developmental delay. Thyroid function test including TSH, T3, and free T4 levels was the important clue for the diagnosis of AHDS of the patient.

Keyword

Allan-Herndon-Dudley Syndrome; monocarboxylate transporter 8 (MCT8); neurodevelopmental delay; movement disorders; thyroid hormone; transporters

MeSH Terms

Brain
Cerebral Palsy
Diagnosis
Dystonia
Humans
Intellectual Disability
Male*
Movement Disorders
Muscle Hypotonia
Neurologic Manifestations
Quadriplegia
Thyroid Function Tests*
Thyroid Gland*
Thyrotropin
Thyroxine
Triiodothyronine
Thyrotropin
Thyroxine
Triiodothyronine
Full Text Links
  • JKCNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr